Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

VeIP Regimen

Known as: VeIP, Velban-Ifosfamide-Platinol Regimen 
An abbreviation for a chemotherapy combination used to treat ovarian and testicular germ cell cancers that have spread. It includes the drugs… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Ovarian germ cell tumors are malignant tumors which commonly develop during childhood, and which are sensitive to chemotherapy… Expand
Is this relevant?
2007
2007
We are grateful to Dr. Larry A. Walker (Director of the National Center for Natural Products Research, Mississippi University… Expand
  • table I
  • table II
Is this relevant?
2006
2006
Objective: The characteristics and risk factors of the long-term ototoxic effect of cisplatin in testicular cancer patients was… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE This study was designed to assess the effectiveness of vinblastine, ifosfamide, and cisplatin (VeIP) as second-line… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE To evaluate the efficacy and toxicity of ifosfamide- and cisplatin-containing chemotherapy as first-line salvage… Expand
Is this relevant?
1995
1995
PURPOSE Ifosfamide-containing therapy with cisplatin plus either etoposide (VIP) or vinblastine (VeIP) can cure of patients with… Expand
Is this relevant?
1994
1994
BACKGROUND Patients with relapsed germ cell cancer (GCT) have a poor prognosis when treated solely with conventional chemotherapy… Expand
Is this relevant?
1992
1992
Sixty-six patients with germ cell tumors (GCTs) refractory to cisplatin plus etoposide/vinblastine-based therapy were treated… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
STUDY OBJECTIVE To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP… Expand
Is this relevant?